Participate in Clinical Trials

Currently, there are no approved disease-modifying treatments for FTD, meaning there are no therapies available that can slow or stop the progression of the disease. However, several promising clinical trials are underway, aiming to target the underlying biological processes—such as abnormal protein accumulation—that contribute to FTD. These trials include efforts to develop drugs that reduce protein build-up, gene therapies for inherited forms, and treatments to protect brain cells from damage.

Here are a list of available websites you can visit to find current clinical trials:

  • Run by the Australian Government.

  • Great for patients and families to understand the process of joining trials.

  • Educational resources.

  • Clinical trials and observational studies across all dementia types.

  • Different study types (overservational, treatments, brain/tissue donation).

  • Educational resources.

Symptom Management and Support

In the absence of disease-modifying therapies, management focuses on managing symptoms and maximising quality of life. Treatment plans are tailored to the individual and often involve a multidisciplinary approach, including:

While there is currently no cure for FTD, this comprehensive, person-centred approach aims to maximise quality of life for individuals and their families. 

Our team is actively involved in research and clinical trials that aim to deliver more effective treatments in the future. Visit Our latest research under About us to learn more.

For more information on behaviour management support and caregiver support visit Support services

For more information on our speech therapy program, visit Participate in speech therapy research under Get involved.